Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05509166 · ClinicalTrials.gov registry record · NA

Affirmative Psychotherapy for Sexual Minority Women's Mental and Behavioral Health

A NA study of Mental Health Issue and Heavy Drinking, sponsored by Yale University.

Recruiting
Registry status
NA
Development phase
450
Enrollment target
1
Study location

NCT05509166: Recruiting NA study of Mental Health Issue and Heavy Drinking, sponsored by Yale University.

NCT05509166 is a NA study of Mental Health Issue and Heavy Drinking that is actively recruiting participants, run by Yale University. The registered enrollment target is 450 participants, below the 2,938-participant average among 52 other Mental Health Issue trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05509166, a NA study of Mental Health Issue and Heavy Drinking, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
NA
Development phase
450 participants
Enrollment target
1
Study location

Study Summary

The purpose of this 2-arm randomized controlled trial is to assess the efficacy of a 10-session lesbian, gay, bisexual, transgender, and queer (LGBTQ)-affirmative cognitive-behavioral psychotherapy (CBT) delivered via telehealth in a large sample of sexual minority women (SMW) in New York, New Jersey and Pennsylvania. The investigators will assess whether the EQuIP (Empowering Queer Identities in Psychotherapy) treatment demonstrates significant reductions in heavy drinking (HD) and mental health symptoms (e.g., depression) compared to LGBTQ-affirmative treatment-as-usual.

Primary Outcome

The proportion of heavy drinking days will be assessed using a 30-day Timeline Followback. The Timeline Followback is a structured interview that will assess alcohol use over the past 30 days. Heavy drinking days are defined as those in which more than four drinks were consumed within a two-hour period.

Interventions

  • BEHAVIORAL LGBTQ-affirmative Cognitive Behavioral Therapy
  • BEHAVIORAL LGBTQ-affirmative Treatment-As-Usual

Study Locations (1)

New York

  • Yale LGBTQ Mental Health Initiative with the Yale School of Public Office - New York

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2023-02-01
Est. Completion 2027-08-01
Phase NA
Yale University

1,492 total trials

What NCT05509166 shows while recruiting

NCT05509166 is an interventional study that assigns participants to a tested intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 2,938-participant average among 52 other Mental Health Issue trials with a reported enrollment target (85% lower).

The record links to 2 conditions, with Mental Health Issue appearing as the primary indexed condition, and to 2 interventions - of which LGBTQ-affirmative Cognitive Behavioral Therapy is the first listed.

NCT05509166 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05509166 about?

NCT05509166 is a clinical study titled "Affirmative Psychotherapy for Sexual Minority Women's Mental and Behavioral Health". The purpose of this 2-arm randomized controlled trial is to assess the efficacy of a 10-session lesbian, gay, bisexual, transgender, and queer (LGBTQ)-affirmative cognitive-behavioral psychotherapy (CBT) delivered via telehealth in a large sample of sexual minority women (SMW) in New York, New Jerse...

What is the current status of trial NCT05509166?

This trial is currently recruiting. It is a NA study. The enrollment target is 450 participants. The study started on 2023-02-01. Estimated completion is 2027-08-01.

What conditions does trial NCT05509166 study?

This clinical trial studies the following conditions: Mental Health Issue, Heavy Drinking.

What interventions are being tested in trial NCT05509166?

The interventions under investigation include: LGBTQ-affirmative Cognitive Behavioral Therapy (BEHAVIORAL), LGBTQ-affirmative Treatment-As-Usual (BEHAVIORAL).

Who is sponsoring clinical trial NCT05509166?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05509166 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mental Health Issue

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05509166's enrollment target sits among peer trials

450 12th of 52 higher than 41 of 52 other Mental Health Issue trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mental Health Issue trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00515060 · 450 participants

    Psychophysical Studies of Cancer Therapy Pain

  • NCT01257269 · 450 participants

    Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

  • NCT03047161 · 450 participants

    Electrophysiology of Fetal Arrhythmia

  • NCT03269630 · 450 participants

    New Orleans Pulmonary Hypertension Biobank

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05509166, the US trial registry maintained by the National Library of Medicine. NCT05509166 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.